Azitra Management
Management criteria checks 1/4
Azitra's CEO is Francisco Salva, appointed in Apr 2021, has a tenure of 3.08 years. total yearly compensation is $427.03K, comprised of 98.4% salary and 1.6% bonuses, including company stock and options. directly owns 0.017% of the company’s shares, worth $1.30K. The average tenure of the management team and the board of directors is 1.6 years and 2 years respectively.
Key information
Francisco Salva
Chief executive officer
US$427.0k
Total compensation
| CEO salary percentage | 98.4% |
| CEO tenure | 3.1yrs |
| CEO ownership | 0.02% |
| Management average tenure | 1.6yrs |
| Board average tenure | 2yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$427k | US$420k | -US$13m |
| Sep 30 2023 | n/a | n/a | -US$15m |
| Jun 30 2023 | n/a | n/a | -US$16m |
| Mar 31 2023 | n/a | n/a | -US$14m |
| Dec 31 2022 | US$404k | US$404k | -US$13m |
| Sep 30 2022 | n/a | n/a | -US$13m |
| Dec 31 2021 | US$1m | US$282k | -US$12m |
Compensation vs Market: Francisco's total compensation ($USD427.03K) is below average for companies of similar size in the US market ($USD661.60K).
Compensation vs Earnings: Francisco's compensation has increased whilst the company is unprofitable.
CEO
Francisco Salva (52 yo)
3.1yrs
Tenure
US$427,030
Compensation
Mr. Francisco D. Salva serves as President, Chief Executive Officer and Director at Azitra Inc. since April 2021. He is an Independent Director at Vincerx Pharma, Inc. (formerly known as Vincera Pharma, In...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 3.1yrs | US$427.03k | 0.017% $ 1.3k | |
| Co-Founder | less than a year | US$182.31k | 1.11% $ 83.1k | |
| CFO, Treasurer & Secretary | 1.6yrs | US$334.73k | 0.18% $ 13.3k |
1.6yrs
Average Tenure
52yo
Average Age
Experienced Management: AZTR's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 3.1yrs | US$427.03k | 0.017% $ 1.3k | |
| Co-Founder | no data | US$182.31k | 1.11% $ 83.1k | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Member of Scientific & Clinical Advisory Board | no data | no data | no data | |
| Independent Director | 5.2yrs | no data | 1.01% $ 75.9k | |
| Member of Scientific & Clinical Advisory Board | no data | no data | no data | |
| Member of Scientific & Clinical Advisory Board | no data | no data | no data | |
| Member of Scientific & Clinical Advisory Board | no data | no data | no data | |
| Member of Scientific & Clinical Advisory Board | no data | no data | no data |
2.0yrs
Average Tenure
52yo
Average Age
Experienced Board: AZTR's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.